Jaguar Health, Inc. (JAGX)
NASDAQ: JAGX · Real-Time Price · USD
3.900
-0.100 (-2.50%)
Jun 5, 2025, 4:00 PM - Market closed

Jaguar Health Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Revenue
11.5511.699.7611.964.349.39
Upgrade
Revenue Growth (YoY)
13.93%19.75%-18.36%175.80%-53.81%62.51%
Upgrade
Cost of Revenue
2.041.962.042.022.333.16
Upgrade
Gross Profit
9.519.737.729.9426.22
Upgrade
Selling, General & Admin
25.5924.0223.0526.712620
Upgrade
Research & Development
15.9616.5418.617.6515.086.41
Upgrade
Operating Expenses
41.5540.5741.6444.3541.0826.41
Upgrade
Operating Income
-32.04-30.83-33.92-34.42-39.07-20.19
Upgrade
Interest Expense
--0.23-6.38-12.72-8.42-2.79
Upgrade
Interest & Investment Income
0.44-----
Upgrade
Other Non Operating Income (Expenses)
-8.88-9.43-4.930.93-2.72-2.51
Upgrade
EBT Excluding Unusual Items
-40.48-40.5-45.23-46.21-50.21-25.48
Upgrade
Asset Writedown
---0.37---0.12
Upgrade
Other Unusual Items
-1.253.7-2.19-2.39-8.21
Upgrade
Pretax Income
-40.48-39.25-41.9-48.4-52.6-33.81
Upgrade
Earnings From Continuing Operations
-40.48-39.25-41.9-48.4-52.6-33.81
Upgrade
Minority Interest in Earnings
0.750.760.60.940.01-
Upgrade
Net Income
-39.73-38.49-41.3-47.45-52.6-33.81
Upgrade
Preferred Dividends & Other Adjustments
-----4.84
Upgrade
Net Income to Common
-39.73-38.49-41.3-47.45-52.6-38.65
Upgrade
Shares Outstanding (Basic)
000---
Upgrade
Shares Outstanding (Diluted)
000---
Upgrade
Shares Change (YoY)
934.82%1809.95%----
Upgrade
EPS (Basic)
-93.54-130.69-2678.17---
Upgrade
EPS (Diluted)
-93.55-130.69-2678.17---
Upgrade
Free Cash Flow
-29.67-29.4-33.24-33.18-34.98-15.29
Upgrade
Free Cash Flow Per Share
-69.86-99.82-2155.63---
Upgrade
Gross Margin
82.34%83.28%79.13%83.11%46.18%66.31%
Upgrade
Operating Margin
-277.33%-263.76%-347.50%-287.85%-901.36%-215.09%
Upgrade
Profit Margin
-343.92%-329.30%-423.11%-396.91%-1213.26%-411.81%
Upgrade
Free Cash Flow Margin
-256.83%-251.52%-340.56%-277.53%-806.83%-162.87%
Upgrade
EBITDA
-30.16-28.93-31.91-32.43-37.36-18.46
Upgrade
EBITDA Margin
-261.07%-247.51%--271.28%--196.69%
Upgrade
D&A For EBITDA
1.881.92.011.981.721.73
Upgrade
EBIT
-32.04-30.83-33.92-34.42-39.07-20.19
Upgrade
EBIT Margin
-277.33%-263.76%--287.85%--215.09%
Upgrade
Revenue as Reported
11.5511.699.76-4.34-
Upgrade
Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q